Company profile: Percutaneous Valve Technologies
1.1 - Company Overview
Company description
- Provider of medical devices for delivering heart valves to treat late-stage aortic stenosis.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Percutaneous Valve Technologies
Bolt Medical
HQ: United States
Website
- Description: Provider of investigational medical devices for calcified arterial lesions, including Bolt IVLTM/Bolt IVL intravascular lithotripsy using laser-based acoustic pressure waves for coronary and peripheral arteries; RESTORE ATK/BTK systems for peripheral arterial disease above/below the knee; and the RESTORE FIH Coronary System, all under clinical evaluation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bolt Medical company profile →
Annexin Pharmaceuticals
HQ: Sweden
Website
- Description: Provider of biotechnology focused on Annexin A5-based therapeutics. Develops ANXV, a human recombinant Annexin A5 that targets phosphatidylserine for acute treatment of cardiovascular diseases and is being investigated for retinal vein occlusion, cancer, and sickle cell disease. ANXV aims to protect cells, modulate immune responses, and reduce vascular inflammation and cellular stress.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Annexin Pharmaceuticals company profile →
BTG
HQ: United Kingdom
Website
- Description: Provider of interventional medicine, pharmaceuticals, and licensing solutions, acquiring, developing, manufacturing, and commercializing products globally. Interventional oncology offerings include beads and TheraSphere Y-90 Glass Microspheres for HCC; other devices include Jetstream Atherectomy System, Vercise Genus DBS, Varithena 1% foam, WaveWriter Alpha SCS, and AcuPulse DUO CO2 Laser.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BTG company profile →
Xenios
HQ: Germany
Website
- Description: Provider of extracorporeal therapy systems delivering minimally invasive disposable lung and heart therapies on a single platform, including the Xenios Console for ECLS in heart and lung failure; MultiSupport GROUND for ground transport requiring extracorporeal gas exchange or circulatory support; Novalung Kits with integrated pressure sensors for blood gas exchange; and iLA activve Kits for gas exchange and temperature control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xenios company profile →
ev3
HQ: United States
Website
- Description: Provider of technology solutions for specialists treating a wide range of vascular diseases and disorders, serving the peripheral vascular and neurovascular markets with a comprehensive portfolio of treatment options, including primary interventional technologies such as peripheral angioplasty.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ev3 company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Percutaneous Valve Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Percutaneous Valve Technologies
2.2 - Growth funds investing in similar companies to Percutaneous Valve Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Percutaneous Valve Technologies
4.2 - Public trading comparable groups for Percutaneous Valve Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →